🔎 Trials Near Me

Akèy › Obèsite › Mississippi › Jackson

Etid klinik pou Obèsite nan Jackson, MS

8 etid pou Obèsite ap chèche patisipan nan sit nan ak bò kote Jackson (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Ap rekriteFaz 3
  • Jackson Heart Clinic, Jackson
Laj 45 a 99 · Tout sèks · Mizajou Sep 22, 2026 · NCT07037433

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Ap rekriteFaz 3
  • AURORA-1 Clinical Site, Jackson
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Ap rekriteFaz 3
  • AURORA-2 Clinical Site, Jackson
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743450

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Ap rekriteFaz 3Volontè an sante akeyi
  • ACCOMPLISH-2 Research Site, Ridgeland · 9 mi lwen
Laj 18 a 79 · Tout sèks · Mizajou Sep 11, 2026 · NCT07654374

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Ap rekriteFaz 3
  • Sky Integrative Medical Center, Ridgeland · 9 mi lwen
Laj 18 a 99 · Tout sèks · Mizajou Aug 27, 2026 · NCT07575399

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Ap rekriteFaz 3
  • Univ of Mississippi Med Center, Jackson
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07567001

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Ap rekriteFaz 3
  • ACCOMPLISH-1 Research Site, Ridgeland · 9 mi lwen
Laj 18 a 79 · Tout sèks · Mizajou Aug 10, 2026 · NCT07654361

The Epidemiology and Pathophysiology of Kidney Disease in HFpEF With Obesity

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • University of Mississippi Medical Center, Jackson
Laj 18 a 75 · Tout sèks · Mizajou Jul 4, 2025 · NCT07052539

Etid Obèsite nan lòt vil

Lòt etid nan Jackson

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.